Back

Dissecting the mechanistic differences between Jervell Lange-Neilson syndrome type 1 and 2 using human induced pluripotent stem cell derived cardiomyocytes

18 April 2026 (15:35 - 16:25)
Organised by: Logo
Congress Presentation Part of: Arrhythmias: genetic and cellular basis Arrhythmias Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Katharine King

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Human atrium-sized in vitro modelling of atrial fibrillation: a new experimental scale for preclinical therapeutic testing
Mr A. Nobacht (Leiden, NL)
Abstract
Presentation thumbnail
Intrinsic cardiac protection against arrhythmia in pulmonary arterial hypertension independent of hypoxia inducible factor 2-alpha activity
Ms A. Sohi (London, GB)
Abstract
Presentation thumbnail
Transcriptional regulation of SCN5A and cardiac conduction by the novel Brugada syndrome associated transcription factor WT1
Doctor F. Bosada (Amsterdam, NL)
Abstract
Presentation thumbnail
Radiation-induced fibroblast activation following stereotactic arrhythmia radioablation (STAR) in pig
Mr L. Nys (Leuven, BE)
Abstract
Presentation thumbnail
Identification of transcription factors driving fibroblast differentiation towards an inflammatory phenotype by single-nucleus multiomics
Doctor Y. Fu (Leuven, BE)
Abstract

Access the full session

Session thumbnail
Arrhythmias: genetic and cellular basis

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

18 April 2026 15:35 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources